Instituto Mexicano del Seguro Social
imss.gob.mxLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
123
Active
21
Phase 3
24
Total enrollment
48,637
Pipeline matrix
Showing 20 of 20 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Dolutegravir | — | — | — | — | — | 1 | |
| Darunavir/Cobicistat | — | — | — | — | — | 1 | |
| Dual therapy: darunavir/cobicistat + lamivudine | — | — | — | — | — | 1 | |
| Triple therapy: darunavir/cobicistat plus tenofovir alafenamide/emtricitabine | — | — | — | — | — | 1 | |
| DTG/3TC | — | — | — | — | — | 1 | |
| Ondansetron Intraperitoneal Lavage | — | — | — | — | — | 1 | |
| Saline Intraperitoneal Lavage | — | — | — | — | — | 1 | |
| Intravenous Lidocaine infusion + Standard Anesthesia | — | — | — | — | — | 1 | |
| Intravenous Dexmedetomidine infusion + Standard Anesthesia | — | — | — | — | — | 1 | |
| Lidocaine + Dexmedetomidine Combination (LIDEX) + Standard Anesthesia | — | — | — | — | — | 1 | |
| 0.9 % Saline Placebo + Standard Anesthesia | — | — | — | — | — | 1 | |
| Integrase inhibitor | — | — | — | — | — | 1 | |
| Doravirine + tenofovir DF + lamivudine | — | — | — | — | — | 1 | |
| Bictegravir | — | — | — | — | 2 | ||
| Dapagliflozin 10 MG Oral | — | — | — | — | — | 2 | |
| Semaglutide | — | — | — | — | — | 2 | |
| Capsaicin Transmucosal Oral Film | — | — | — | — | — | 1 | |
| Incobotulinum Toxin A | — | — | — | — | — | 1 | |
| Glucocorticoid | — | — | — | — | — | 1 | |
| Botulinum Toxin Type A | — | — | — | — | — | 1 |
Next readouts
- 2025-01-01
- 2025-11-14
- 2025-12-21
- 2026-03-31
- 2026-07-10
- 2026-08
- 2026-09-30
- 2026-12-01
- 2027-01
- 2027-02-01
Top conditions
- Postoperative Pain3
- HIV Infection3
- Covid193
- Bariatric Surgery Candidate3
- Mandibular Fractures2
- HIV2
- Anxiety2
- Anesthesia and Analgesia2
Frequently asked questions about Instituto Mexicano del Seguro Social
- How many clinical trials does Instituto Mexicano del Seguro Social have on ClinicalTrials.gov?
- Instituto Mexicano del Seguro Social is listed as the lead sponsor on 123 clinical trials in ClinicalTrials.gov, 21 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Instituto Mexicano del Seguro Social's trials are in Phase 3?
- 24 of Instituto Mexicano del Seguro Social's trials are in Phase 3, spread across 20 active drug programs.
- What therapeutic areas does Instituto Mexicano del Seguro Social focus on?
- Instituto Mexicano del Seguro Social's most-studied conditions on ClinicalTrials.gov are Postoperative Pain, HIV Infection, Covid19, Bariatric Surgery Candidate, Mandibular Fractures.
- When are Instituto Mexicano del Seguro Social's next clinical trial readouts?
- Instituto Mexicano del Seguro Social has 10 upcoming primary-completion readouts tracked here; the soonest is “Clinical Effects of Incobotulinum Toxin vs Corticosteroid in Plantar Fascitis”, expected around 2025-01-01.